CLINICAL_TRIALS
trial_result
· 2017-06-06
Clinical Trial Update: Safety and Efficacy Study of T-Guard to Treat Steroid-resistant Acute GVHD [Phase 1, Phase 2]
Summary
Completed Phase 1/2 study evaluating safety and efficacy of T-Guard for steroid-resistant acute graft-versus-host disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Xenikos | Conditions: Graft vs Host Disease | Phase 1, Phase 2 | Status: COMPLETED